Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-03-06 @ 12:59 PM
Study NCT ID:
NCT00675103
Status:
COMPLETED
Last Update Posted:
2011-06-28
First Post:
2008-05-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
Sponsor:
Savient Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C0409
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Chief Medical Officer
Old Organization:
Savient Pharmaceuticals